• Home
  • Pembrolizumab plus chemotherapy in triple-negative breast cancer - Authors' reply.

Pembrolizumab plus chemotherapy in triple-negative breast cancer - Authors' reply.

Author List
Cortes J, Rugo HS, Guo Z, Karantza V, Schmid P
Publication
Lancet (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/212338669
Publication Year
2021
PubMed ID
34217393
Publication Title
Cortes J, Rugo HS, Guo Z, Karantza V, Schmid P. Pembrolizumab plus chemotherapy in triple-negative breast cancer - Authors' reply. Lancet. 2021 07 03; 398(10294):24-25.